176 related articles for article (PubMed ID: 35750581)
1. Re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.006.
Wei Y; Zhang R; Lin L
Eur Urol; 2022 Sep; 82(3):e88. PubMed ID: 35750581
[No Abstract] [Full Text] [Related]
2. Reply to Yongbao Wei, Ruochen Zhang, and Le Lin's Letter to the Editor re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:e88.
Ljungberg B; Bedke J; Capitanio U; Bex A
Eur Urol; 2022 Oct; 82(4):e111-e112. PubMed ID: 35773149
[No Abstract] [Full Text] [Related]
3. Re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2023;83:3-5.
Tang Y; Hu X; Wu K; Shao Y; Li X
Eur Urol; 2023 Mar; 83(3):e73. PubMed ID: 36526493
[No Abstract] [Full Text] [Related]
4. Re: Laurence Albiges, Tom Powles, Michael Staehler, et al. Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-Cell Renal Cell Carcinoma. Eur Urol 2019;76:151-6: Active Surveillance in Metastatic Renal Cell Cancer: Missing a Chance for Cure?
de Joode K; van der Veldt AAM
Eur Urol; 2020 Mar; 77(3):e76-e77. PubMed ID: 31610901
[No Abstract] [Full Text] [Related]
5. Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.038: Cytoreductive Nephrectomy: To Whom and When?
Mollica V; Rizzo A; Massari F
Eur Urol Oncol; 2020 Aug; 3(4):559-560. PubMed ID: 32553708
[No Abstract] [Full Text] [Related]
6. Reply to Yaxiong Tang, Xu Hu, Kan Wu, Yanxiang Shao, and Xiang Li's Letter to the Editor re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2022;83:3-5.
Capitanio U; Bedke J; Albiges L; Volpe A; Giles RH; Hora M; Marconi L; Klatte T; Abu-Ghanem Y; Dabestani S; Fernández Pello S; Hofmann F; Kuusk T; Campi R; Tahbaz R; Powles T; Ljungberg B; Bex A
Eur Urol; 2023 Mar; 83(3):e74-e75. PubMed ID: 36526491
[No Abstract] [Full Text] [Related]
7. Re: Michele Gnech, Lisette 't Hoen, Alexandra Zachou, et al. Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.12.005.
Zhong P; Liu X; Liao L
Eur Urol; 2024 Apr; ():. PubMed ID: 38614821
[No Abstract] [Full Text] [Related]
8. Re: Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albigès, et al. Cabazitaxel remains active in patients progressing after docetaxel followed by novel androgen receptor pathway targeted therapies. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.015.
van Soest RJ; de Wit R; van Weerden WM
Eur Urol; 2014 Oct; 66(4):e71-2. PubMed ID: 25012524
[No Abstract] [Full Text] [Related]
9. Re: Mauro Gacci, Vasileios I. Sakalis, Markos Karavitakis, et al. European Association of Urology Guidelines on Male Urinary Incontinence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.05.012.
Lv M; Luo X; Chen Y
Eur Urol; 2022 Oct; 82(4):e118. PubMed ID: 35961869
[No Abstract] [Full Text] [Related]
10. Reply to Ping Zhong, Xin Liu, and Limin Liao's Letter to the Editor re: Michele Gnech, Lisette 't Hoen, Alexandra Zachou, et al. Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.12.005.
Gnech M; 't Hoen L; Burgu B; Radmayr C
Eur Urol; 2024 May; ():. PubMed ID: 38735821
[No Abstract] [Full Text] [Related]
11. Reply to Meny Lv, Xufei Luo, and Yaolong Chen's Letter to the Editor re: Mauro Gacci, Vasileios I. Sakalis, Markos Karavitakis, et al. European Association of Urology Guidelines on Male Urinary Incontinence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.05.012.
Gacci M; Sakalis VI; Karavitakis M; Gravas S
Eur Urol; 2022 Oct; 82(4):e119-e120. PubMed ID: 35945088
[No Abstract] [Full Text] [Related]
12. Re: Maria J. Ribal, Philip Cornford, Alberto Briganti, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.056: Metastatic Prostate Cancer and COVID-19: Do Current Data Allow Modification of Established Treatment Recommendations?
Thomas C; Grüllich C; Erb HHH
Eur Urol Focus; 2020 Sep; 6(5):1135-1136. PubMed ID: 32534970
[No Abstract] [Full Text] [Related]
13. Re: Longbin Xiong, Jane K. Nguyen, Yulu Peng, et al. What Happens to the Preserved Renal Parenchyma After Clamped Partial Nephrectomy? Eur Urol. 2022;81:492-500. https://doi.org/10.1016/j.eururo.2021.12.036.
Ren S; Zhong S; Fan S; Li X; Zhou F; Wang D
Eur Urol; 2022 Aug; 82(2):e49. PubMed ID: 35570147
[No Abstract] [Full Text] [Related]
14. Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End.
Massari F; Di Nunno V; Santoni M; Gatto L; Mollica V; Porta C
Eur Urol Oncol; 2019 Sep; 2(5):603-604. PubMed ID: 31411982
[No Abstract] [Full Text] [Related]
15. Re: Geraldine Pignot, Antoine Thiery-Vuillemin, Jochen Walz, et al. Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.018: The Next Surgical Frontier in Kidney Cancer: Nephrectomy After Immune Checkpoint Inhibition.
Singla N; Margulis V
Eur Urol; 2020 Aug; 78(2):e79-e80. PubMed ID: 32362497
[No Abstract] [Full Text] [Related]
16. Re: Marc-Oliver Grimm, Antione G. van der Heijden, Marc Colombel, et al. Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS". Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.066.
Karabay E; Tınay İ
Eur Urol; 2020 Oct; 78(4):e161-e162. PubMed ID: 32682616
[No Abstract] [Full Text] [Related]
17. Re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.06.002.
Montorsi F; Larcher A; Capitanio U
Eur Urol Focus; 2021 Mar; 7(2):406. PubMed ID: 31564640
[No Abstract] [Full Text] [Related]
18. Re: Oscar Reig Torras, Akhilesh Mishra, Alana Christie, et al. Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.003.
Wang Z; Zhao Y; Zhang Y
Eur Urol; 2022 May; 81(5):e120. PubMed ID: 35232603
[No Abstract] [Full Text] [Related]
19. Re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting Functional Outcomes After Partial and Radical Nephrectomy. Eur Urol 2019;75:766-72: Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
Takahashi T
Eur Urol; 2019 Sep; 76(3):e65-e66. PubMed ID: 31164251
[No Abstract] [Full Text] [Related]
20. Reply to Emre Karabay and İlker Tınay's Letter to the Editor re: Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS". Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.066.
Grimm MO; Caris C; Witjes WPJ;
Eur Urol; 2020 Oct; 78(4):e163-e164. PubMed ID: 32693930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
